LI Ji, LI Xiang, HU Xiaoyang, et al. Research progress of regulation of miRNA on myocardial ischemia reperfusion injury by traditional Chinese medicine[J]. Shanghai Journal of Traditional Chinese Medicine, 2020,54(3):97-100.
LI Ji, LI Xiang, HU Xiaoyang, et al. Research progress of regulation of miRNA on myocardial ischemia reperfusion injury by traditional Chinese medicine[J]. Shanghai Journal of Traditional Chinese Medicine, 2020,54(3):97-100. DOI: 10.16305/j.1007-1334.2020.03.025.
This paper reviews the latest research progress in the treatment of myocardial ischemia reperfusion injury(MIRI)by regulating micro ribonucleic acid(miRNA)as a target with traditional Chinese medicine monomer(ginsenoside 1, apigenin, salvianolic acid B, luteolin), compound prescription(Yiqi Huoxue compound, Tongxinluo)and acupuncture[electroacupuncture pretreatment, needling neiguan(PC6) point by electroacupuncture, needling neiguan(PC6) point in both sides by electroacupuncture in vivo and microcurrent pretreatment in vitro], which provides an entry point for traditional Chinese medicine treatment of myocardial ischemia reperfusion injury and related prognosis intervention.
关键词
心肌缺血再灌注损伤miRNA中医药疗法综述
Keywords
myocardial ischemia reperfusion injurymiRNAtraditional Chinese medicine therapyreview